BICYCLE THERAPEUTICS PLC - Common Stock (BCYC)
CUSIP: 088786108
Q3 2025 13F Holders as of 30 Sep 2025
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 49,984,905
- Total 13F shares
- 36,906,185
- Share change
- -4,294,502
- Total reported value
- $285,619,779
- Put/Call ratio
- 12%
- Price per share
- $7.74
- Number of holders
- 99
- Value change
- -$29,768,237
- Number of buys
- 48
- Number of sells
- 44
Quarterly Holders Quick Answers
What is CUSIP 088786108?
CUSIP 088786108 identifies BCYC - BICYCLE THERAPEUTICS PLC - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 088786108:
Top shareholders of BCYC - BICYCLE THERAPEUTICS PLC - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BAKER BROS. ADVISORS LP |
13F
|
Company |
22%
|
10,885,357
|
$75,653,231 | — | 30 Jun 2025 | |
| Kate Bingham |
3/4/5
|
Director |
—
class O/S missing
|
1,870,379
|
$32,731,633 | — | 13 Jul 2021 | |
| Forbion Growth Opportunities Fund II Cooperatief U.A. |
13D/G
|
— |
7.3%
|
3,452,330
|
$28,343,629 | $0 | 21 Nov 2024 | |
| FCPM III SERVICES B.V. |
13F
|
Company |
6.9%
|
3,452,330
|
$23,993,694 | — | 30 Jun 2025 | |
| ARMISTICE CAPITAL, LLC |
13F
|
Company |
5.6%
|
2,800,000
|
$19,460,000 | — | 30 Jun 2025 | |
| WESTFIELD CAPITAL MANAGEMENT CO LP |
13F
|
Company |
5.6%
|
2,780,491
|
$19,324,412 | — | 30 Jun 2025 | |
| Point72 Asset Management, L.P. |
13D/G
13F
|
Company |
3.9%
|
1,860,317
|
$14,882,536 | -$15,032,008 | 30 Jun 2025 | |
| Siren, L.L.C. |
13F
|
Individual |
4%
|
2,012,752
|
$13,988,626 | — | 30 Jun 2025 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
2.9%
|
1,468,393
|
$10,206,000 | — | 30 Jun 2025 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
2.9%
|
1,443,619
|
$10,033,152 | — | 30 Jun 2025 | |
| Deep Track Capital, LP |
13D/G
13F
|
Company |
2.4%
|
1,203,244
|
$9,625,952 | -$12,943,416 | 30 Jun 2025 | |
| Long Focus Capital Management, LLC |
13F
|
Company |
2.6%
|
1,317,293
|
$9,155,186 | — | 30 Jun 2025 | |
| S.c.a. Candriam |
13F
|
Individual |
2.3%
|
1,172,387
|
$8,148,437 | — | 30 Jun 2025 | |
| BNP Paribas Asset Management Holding S.A. |
13F
|
Company |
2.1%
|
1,041,456
|
$7,238,000 | — | 30 Jun 2025 | |
| MORGAN STANLEY |
13F
|
Company |
2.1%
|
1,037,153
|
$7,208,213 | — | 30 Jun 2025 | |
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD |
13F
|
Company |
2%
|
993,743
|
$6,906,514 | — | 30 Jun 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
1.7%
|
830,634
|
$5,772,906 | — | 30 Jun 2025 | |
| PRINCIPAL FINANCIAL GROUP INC |
13F
|
Company |
1.4%
|
697,267
|
$4,846,005 | — | 30 Jun 2025 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
1.4%
|
698,501
|
$4,840,000 | — | 30 Jun 2025 | |
| Jefferies Financial Group Inc. |
13F
|
Company |
0.92%
|
461,100
|
$3,204,645 | — | 30 Jun 2025 | |
| Woodline Partners LP |
13F
|
Company |
0.72%
|
362,325
|
$2,518,159 | — | 30 Jun 2025 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.64%
|
318,400
|
$2,212,880 | — | 30 Jun 2025 | |
| PLATINUM INVESTMENT MANAGEMENT LTD |
13F
|
Company |
0.57%
|
285,381
|
$1,983,398 | — | 30 Jun 2025 | |
| AXA S.A. |
13F
|
Company |
0.56%
|
280,152
|
$1,947,056 | — | 30 Jun 2025 | |
| SILVERCREST ASSET MANAGEMENT GROUP LLC |
13F
|
Company |
0.53%
|
265,693
|
$1,846,566 | — | 30 Jun 2025 | |
| BlackRock, Inc. |
13F
|
Company |
0.53%
|
264,348
|
$1,837,219 | — | 30 Jun 2025 | |
| Palo Alto Investors LP |
13F
|
Company |
0.5%
|
248,934
|
$1,730,091 | — | 30 Jun 2025 | |
| Eversept Partners, LP |
13F
|
Company |
0.42%
|
211,469
|
$1,469,710 | — | 30 Jun 2025 | |
| Handelsbanken Fonder AB |
13F
|
Company |
0.4%
|
200,000
|
$1,390,000 | — | 30 Jun 2025 | |
| Nicholas Keen |
3/4/5
|
CHIEF SCIENTIFIC OFFICER |
—
mixed-class rows
|
125,024
mixed-class rows
|
$1,355,631 | — | 03 Jul 2024 | |
| TD ASSET MANAGEMENT INC |
13F
|
Company |
0.39%
|
193,092
|
$1,341,989 | — | 30 Jun 2025 | |
| Legal & General Group Plc |
13F
|
Company |
0.35%
|
174,910
|
$1,213,876 | — | 30 Jun 2025 | |
| PINNACLE ASSOCIATES LTD |
13F
|
Company |
0.34%
|
171,953
|
$1,195,073 | — | 30 Jun 2025 | |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) |
13F
|
Company |
0.29%
|
143,800
|
$999,410 | — | 30 Jun 2025 | |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE |
13F
|
Company |
0.28%
|
140,492
|
$976,419 | — | 30 Jun 2025 | |
| Santiago Arroyo |
3/4/5
|
CHIEF DEVELOPMENT OFFICER |
—
mixed-class rows
|
197,627
mixed-class rows
|
$973,013 | — | 02 Jan 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.28%
|
139,467
|
$969,296 | — | 30 Jun 2025 | |
| HARBOR CAPITAL ADVISORS, INC. |
13F
|
Company |
0.28%
|
138,661
|
$964,000 | — | 30 Jun 2025 | |
| Nigel Crockett |
3/4/5
|
CHIEF BUSINESS OFFICER |
—
mixed-class rows
|
72,803
mixed-class rows
|
$753,032 | — | 02 Jan 2025 | |
| Janney Montgomery Scott LLC |
13F
|
Company |
0.2%
|
100,291
|
$697,000 | — | 30 Jun 2025 | |
| Soleus Capital Management, L.P. |
13F
|
Company |
0.2%
|
100,000
|
$695,000 | — | 30 Jun 2025 | |
| Pierre Legault |
3/4/5
|
Director |
—
mixed-class rows
|
71,000
mixed-class rows
|
$690,000 | — | 02 Jan 2025 | |
| Dominic Smethurst |
3/4/5
|
Chief Medical Officer |
—
mixed-class rows
|
71,699
mixed-class rows
|
$642,233 | — | 03 Jan 2023 | |
| Cubist Systematic Strategies, LLC |
13F
|
Company |
0.18%
|
87,717
|
$609,633 | — | 30 Jun 2025 | |
| MONIMUS CAPITAL MANAGEMENT, LP |
13F
|
Company |
0.17%
|
85,224
|
$592,307 | — | 30 Jun 2025 | |
| Richard N. Kender |
3/4/5
|
Director |
—
mixed-class rows
|
35,500
mixed-class rows
|
$570,860 | — | 02 Jan 2025 | |
| Lee Kalowski |
3/4/5
|
President and CFO |
—
class O/S missing
|
30,309
|
$530,408 | — | 03 Apr 2023 | |
| MOORE CAPITAL MANAGEMENT, LP |
13F
|
Company |
0.15%
|
75,000
|
$521,250 | — | 30 Jun 2025 | |
| Rangeley Capital, LLC |
13F
|
Company |
0.15%
|
75,000
|
$521,250 | — | 30 Jun 2025 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.14%
|
70,200
|
$487,890 | — | 30 Jun 2025 |
Institutional Holders of BICYCLE THERAPEUTICS PLC - Common Stock (BCYC) as of Q3 2025
As of 30 Sep 2025,
BICYCLE THERAPEUTICS PLC - Common Stock (BCYC) was held by
99 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
36,906,185 shares.
The largest 10 holders included
BAKER BROS. ADVISORS LP, FCPM III SERVICES B.V., ARMISTICE CAPITAL, LLC, WESTFIELD CAPITAL MANAGEMENT CO LP, Siren, L.L.C., Long Focus Capital Management, LLC, PRICE T ROWE ASSOCIATES INC /MD/, ACADIAN ASSET MANAGEMENT LLC, Candriam S.C.A., and PRINCIPAL FINANCIAL GROUP INC.
This page lists
99
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2025 vs Q2 2025 Across Filers
Q2 2025 holders
110
Q3 2025 holders
99
Holder diff
-11
| Investor | Q2 2025 Shares | Q3 2025 Shares | Share Diff | Share Chg % | Q2 2025 Value $ | Q3 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.